Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC
Status:
Not yet recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore whether rectal artery infusion chemotherapy combined
with anti-PD1 antibody is an effective neoadjuvant therapy for the microsatellite stable
locally advanced rectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University